Psychiatry and Neurology, Neurology · Plymouth Meeting, PA
NPI
1528156635
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
531 West Germantown Pike, Suite 203
Plymouth Meeting, PA, 19462
Phone (610) 825-0610
Groups this clinician bills Medicare through
Medicare paid, 2024
$48K
465 services
Medicare patients, 2024
212
Average age 75
Drug cost, 2024
$1.5M
2,476 prescriptions
Company payments, 2025
$1,379
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stephen Sacks was code 99214 (office e&m - established), 213 times for 133 patients. In total Stephen Sacks billed 465 services in 14 codes, and Medicare paid $48K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 213 | 133 | $94.76 | $20K |
| 95886 Electrical Nerve Conductivity | Office | 64 | 31 | $77.48 | $4,959 |
| 99205 Office E&M - New | Office | 61 | 61 | $161.19 | $9,832 |
| 95911 Electrical Nerve Conductivity | Office | 32 | 32 | $171.80 | $5,498 |
| 95885 Electrical Nerve Conductivity | Office | 32 | 16 | $47.38 | $1,516 |
| 99203 Office E&M - New | Office | 31 | 31 | $76.24 | $2,364 |
| 95910 Electrical Nerve Conductivity | Office | 14 | 14 | $142.38 | $1,993 |
By year: 2022 $53K for 485 services; 2023 $57K for 545 services; 2024 $48K for 465 services.
Medicare prescription drug claims, 2024
In 2024, the drug Stephen Sacks prescribed most often to Medicare patients was Carbidopa-Levodopa Er (Carbidopa/Levodopa), with 185 prescriptions and refills. In total Stephen Sacks wrote 2,476 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 185 | 401 | 48 | $12K |
| Levetiracetam Generic | 151 | 279 | 30 | $5,679 |
| Gabapentin Generic | 120 | 178 | 30 | $1,525 |
| Clonazepam Generic | 104 | 119 | 14 | $1,206 |
| Memantine Hcl Generic | 90 | 179 | 24 | $2,550 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 85 | 141 | 19 | $2,202 |
| Tizanidine Hcl Generic | 82 | 137 | 19 | $1,799 |
| Donepezil Hcl Generic | 72 | 161 | 21 | $853 |
| Rasagiline Mesylate Generic | 64 | 138 | 16 | $14K |
| Baclofen Generic | 63 | 82 | Under 11 | $617 |
| Diazepam Generic | 61 | 71 | Under 11 | $6,245 |
| Pregabalin Generic | 60 | 77 | 14 | $1,663 |
| Carbamazepine Generic | 52 | 106 | 11 | $3,154 |
| Tramadol Hcl Generic | 48 | 48 | Under 11 | $245 |
| Escitalopram Oxalate Generic | 46 | 76 | Under 11 | $348 |
Brand drugs: 286 claims; generic drugs: 2,179 claims; opioid claims: 51.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stephen Sacks $1,379 ($1,379 in general payments such as food, travel and fees) from 14 companies. The largest payer was Neurocrine BioSciences, Inc. with $316.
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. NBIX | 13 | $316 |
| EMD Serono, Inc. MRK.DE | 11 | $282 |
| Argenx US, Inc. ARGX | 3 | $240 |
| TG Therapeutics, Inc. TGTX | 2 | $155 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $112 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $62.66 |
| ANI Pharmaceuticals, Inc. ANIP | 2 | $42.82 |
| Astellas Pharma US Inc 4503.T | 1 | $30.49 |
| Blue Earth Diagnostics | 1 | $30.28 |
| Teva Pharmaceuticals USA, Inc. TEVA | 1 | $25.14 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.